Christopher Heaphy
Christopher Heaphy
Assistant Professor, Department of Medicine, Boston University School of Medicine
Verified email at - Homepage
Cited by
Cited by
Altered telomeres in tumors with ATRX and DAXX mutations
CM Heaphy, RF De Wilde, Y Jiao, AP Klein, BH Edil, C Shi, C Bettegowda, ...
Science 333 (6041), 425-425, 2011
Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas
Y Jiao, PJ Killela, ZJ Reitman, BA Rasheed, CM Heaphy, RF De Wilde, ...
Oncotarget 3 (7), 709, 2012
Tracking the clonal origin of lethal prostate cancer
MC Haffner, T Mosbruger, DM Esopi, H Fedor, CM Heaphy, DA Walker, ...
The Journal of clinical investigation 123 (11), 4918-4922, 2013
Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes
CM Heaphy, AP Subhawong, SM Hong, MG Goggins, EA Montgomery, ...
The American journal of pathology 179 (4), 1608-1615, 2011
Mutation of a single allele of the cancer susceptibility gene BRCA1 leads to genomic instability in human breast epithelial cells
H Konishi, M Mohseni, A Tamaki, JP Garay, S Croessmann, S Karnan, ...
Proceedings of the National Academy of Sciences 108 (43), 17773-17778, 2011
Loss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic …
RF De Wilde, CM Heaphy, A Maitra, AK Meeker, BH Edil, CL Wolfgang, ...
Modern Pathology 25 (7), 1033-1039, 2012
Telomeres: prognostic markers for solid tumors
M Bisoffi, CM Heaphy, JK Griffith
International journal of cancer 119 (10), 2255-2260, 2006
Mammary field cancerization: molecular evidence and clinical importance
CM Heaphy, JK Griffith, M Bisoffi
Breast cancer research and treatment 118 (2), 229-239, 2009
Telomere length and pulse pressure in newly diagnosed, antipsychotic-naive patients with nonaffective psychosis
E Fernandez-Egea, M Bernardo, CM Heaphy, JK Griffith, E Parellada, ...
Schizophrenia bulletin 35 (2), 437-442, 2009
Association between cancer-free survival and telomere DNA content in prostate tumors
CA Fordyce, CM Heaphy, NE Joste, AY Smith, WC Hunt, JK Griffith
The Journal of urology 173 (2), 610-614, 2005
Telomere DNA content and allelic imbalance demonstrate field cancerization in histologically normal tissue adjacent to breast tumors
CM Heaphy, M Bisoffi, CA Fordyce, CM Haaland, WC Hines, NE Joste, ...
International journal of cancer 119 (1), 108-116, 2006
Markers of fibrosis and epithelial to mesenchymal transition demonstrate field cancerization in histologically normal tissue adjacent to breast tumors
KA Trujillo, CM Heaphy, M Mai, KM Vargas, AC Jones, P Vo, KS Butler, ...
International journal of cancer 129 (6), 1310-1321, 2011
Abnormal glucose tolerance, white blood cell count, and telomere length in newly diagnosed, antidepressant-naive patients with depression
C Garcia-Rizo, E Fernandez-Egea, BJ Miller, C Oliveira, A Justicia, ...
Brain, behavior, and immunity 28, 49-53, 2013
Molecular and morphologic correlates of the alternative lengthening of telomeres phenotype in high‐grade astrocytomas
DN Nguyen, CM Heaphy, RF De Wilde, BA Orr, Y Odia, CG Eberhart, ...
Brain Pathology 23 (3), 237-243, 2013
Telomere content correlates with stage and prognosis in breast cancer
CA Fordyce, CM Heaphy, M Bisoffi, JL Wyaco, NE Joste, A Mangalik, ...
Breast cancer research and treatment 99 (2), 193-202, 2006
Alternative lengthening of telomeres in primary pancreatic neuroendocrine tumors is associated with aggressive clinical behavior and poor survival
JY Kim, JA Brosnan-Cashman, S An, SJ Kim, KB Song, MS Kim, MJ Kim, ...
Clinical Cancer Research 23 (6), 1598-1606, 2017
Prostate cancer cell telomere length variability and stromal cell telomere length as prognostic markers for metastasis and death
CM Heaphy, GS Yoon, SB Peskoe, CE Joshu, TK Lee, E Giovannucci, ...
Cancer discovery 3 (10), 1130-1141, 2013
Circulating leukocyte telomere length and risk of overall and aggressive prostate cancer
B Julin, I Shui, CM Heaphy, CE Joshu, AK Meeker, E Giovannucci, ...
British journal of cancer 112 (4), 769-776, 2015
Enhancer signatures stratify and predict outcomes of non-functional pancreatic neuroendocrine tumors
P Cejas, Y Drier, KMA Dreijerink, LAA Brosens, V Deshpande, CB Epstein, ...
Nature medicine 25 (8), 1260-1265, 2019
The potential utility of telomere‐related markers for cancer diagnosis
CM Heaphy, AK Meeker
Journal of cellular and molecular medicine 15 (6), 1227-1238, 2011
The system can't perform the operation now. Try again later.
Articles 1–20